Journey Medical Corporation

NASDAQ:DERM

Drug Manufacturers - Specialty & Generic

Healthcare
$3.69 +0.99%

+$0.06 today

Market cap
$104.15M
Beta
1.10
P/E (TTM)
-17.0
EPS (TTM)
-$0.35
52W Low $4.31High $9.56

Volume 0.25M

Average 0.28M

DERM Account Payables

Amounts the company owes suppliers for goods and services received.

Journey Medical CorporationNASDAQ: DERM

Account Payables · Q1 FY2026 · quarter ended Mar 2026

Account payables falls 39.8% from a year ago

Account payables stood at $8.67M at the end of Q1 FY2026, down 39.8% from a year earlier and down 6.8% from the prior quarter. Over 3 fiscal years it compounded at -36.9% a year.

Context

  • Account payables amounted to 9.5% of total assets at the end of Q1 FY2026, down 7.5 pp from a year earlier.
  • Account payables increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether account payables keeps falling in the next quarterly balance sheet after a -39.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$8.67M-6.8% QoQ
Last fiscal yearDec 2025
$9.31M-42.0% YoY
Year agoMar 2025
$14.4M-39.8% since
Account Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-39.8%——
1 year-42.0%——
3-year CAGR-36.9%——
5-year CAGR——
10-year CAGR——

Account Payables history

USD · from the balance sheet

Latest · FY2025
9.31M USD
Year-over-year change
-42.0%
4-year CAGR
-20.1%

Account Payables vs competitors

How DERM compares with its peers on the latest reported figures

  • Peers report in different currencies, so account payables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -39.8% is the lowest of 10, against a peer median of +19.0%.
  • Account payables amounts to 9.5% of total assets for DERM, versus a peer median of 8.7%.
DERM Competitors
Account Payables for DERM and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OGIOrganigram Global Inc.Mar 2026CA$73.33M CAD+16.4%—14.0%
IVAInventiva S.A.Dec 2025€26.01M EUR-20.9%+10.3%10.4%
NYXHNyxoah S.A.Mar 2026€12.69M EUR+36.2%+94.2%12.9%
OSUROraSure Technologies, Inc.Mar 2026$10.63M USD+35.9%-44.4%2.8%
DERMJourney Medical CorporationMar 2026$8.67M USD-39.8%-36.9%9.5%
MDWDMediWound Ltd.Mar 2026$7.41M USD+48.4%-13.9%9.3%
OBIOOrchestra BioMed Holdings, Inc.Mar 2026$6.31M USD+13.5%+15.4%6.3%
FENCFennec Pharmaceuticals Inc.Mar 2026$6.28M USD+19.0%+24.6%8.7%
HSDTSolana CompanyMar 2026$2M USD+62.7%+44.5%1.0%
RNACCartesian Therapeutics, Inc.Mar 2026$1.6M USD-23.8%+59.7%0.6%
Peer median (excluding DERM) —+19.0%+20.0%8.7%

Competitors are the stored peer set for DERM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents49.08M32M27.44M20.31M24.09M
Short-term Investments00000
Net Receivables23.11M28.21M15.22M10.23M29.78M
Inventory9.86M14.16M10.21M14.43M9.62M
Other Current Assets2.44M3.31M3.59M3.21M3.38M
Total Current Assets84.49M77.68M56.46M48.18M66.87M
Property, Plant & Equipment (Net)89K189K101K199K111K
Goodwill00000
Intangible Assets12.55M27.2M20.29M31.86M27.61M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets150K95K6K00
Total Non-current Assets12.79M27.48M20.39M32.06M27.72M
Total Assets97.28M105.16M76.85M80.24M94.59M
Account Payables22.81M36.98M16.08M16.05M9.31M
Short-term Debt812K2.95M3M625K0
Tax Payables8K35K53K60K70K
Deferred Revenue0053K00
Other Current Liabilities24.59M14.1M4.08M14.45M9.57M
Total Current Liabilities51.61M66.83M41.87M35.18M37.44M
Long-term Debt3.63M19.83M14.62M24.88M25.28M
Deferred Tax Liabilities8K0000
Deferred Revenue (Non-current)(8K)0000
Other Non-current Liabilities3.64M1.41M000
Total Non-current Liabilities3.64M21.35M14.63M25M25.3M
Total Liabilities55.24M88.18M56.5M60.17M62.74M
Common Stock2K2K2K2K2K
Retained Earnings(38.87M)(68.5M)(72.36M)(87.03M)(98.46M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity42.04M16.98M20.35M20.07M31.85M
Total Debt910K22.97M17.73M25.71M25.4M
Net Debt(48.17M)(9.04M)(9.71M)5.4M1.31M

Journey Medical Corporation

NASDAQ:DERM

Intrinsic Alpha fair value

Locked

Current Price

$3.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.